[The neurologic manifestations of toxoplasmosis].
D000293:Adolescent; D000328:Adult; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011739:Pyrimethamine / Q000627:therapeutic use; D013118:Spinal Cord Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013449:Sulfonamides / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D014125:Toxoplasmosis, Congenital / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy
D013449:Sulfonamides; D011739:Pyrimethamine
Die neurologischen Erscheinungsformen der Toxoplasmose